Our EBPS-AD software application is developed based on a decade of Alzheimer’s research progress supported by the National Institutes of Health in the laboratory of Shi-Jiang Li, Ph.D.
During the last 10 years, Dr. Li’s research lab at Medical College of Wisconsin, pioneered a new neuroimaging approach that used resting-state functional connectivity MRI (fcMRI) methods to mark network dysfunction in AD.
Our EBPS-AD software application can assess disease severity across the full spectrum of the AD disease continuum on an individual subject basis. The EBPS-AD results can help a trained physician to assess whether the subject is Cognitively Normal, Mild Cognitive Impairment, or Alzheimer’s Disease. The report is saved in PDF file format and/or stored in an electronic medical record.
16600 W National Avenue
New Berlin, WI 53151